China Resources Medical Holdings Co., Ltd.

As of December 31, 2025, China Resources Medical Holdings Co., Ltd. carries a market capitalization of 4.06B, placing it among publicly traded companies globally. Its enterprise value stands at 5.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Resources Medical Holdings Co., Ltd.'s next confirmed earnings release is scheduled for March 30, 2027.

As of December 31, 2025, China Resources Medical Holdings Co., Ltd. has 1.26B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, China Resources Medical Holdings Co., Ltd. maintains a current ratio of 0.64, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, China Resources Medical Holdings Co., Ltd.'s stock has declined approximately 32.51% over the past 52 weeks. The 50-day moving average sits at 2.46, while the 200-day moving average is 2.73.

As of December 31, 2025, China Resources Medical Holdings Co., Ltd. holds 1.05B in cash and equivalents against 949.40M in total debt, resulting in a net debt position of -310.33M. Total book value stands at 7.29B, with working capital of -1.76B providing operational flexibility.